132 related articles for article (PubMed ID: 34563964)
1. Development of [
Wong SW; Vivash L; Mudududdla R; Nguyen N; Hermans SJ; Shackleford DM; Field J; Xue L; Aprico A; Hancock NC; Haskali M; Stashko MA; Frye SV; Wang X; Binder MD; Ackermann U; Parker MW; Kilpatrick TJ; Baell JB
Eur J Med Chem; 2021 Dec; 226():113822. PubMed ID: 34563964
[TBL] [Abstract][Full Text] [Related]
2. Syntheses and in vitro evaluation of new S1PR1 compounds and initial evaluation of a lead F-18 radiotracer in rodents.
Luo Z; Rosenberg AJ; Liu H; Han J; Tu Z
Eur J Med Chem; 2018 Apr; 150():796-808. PubMed ID: 29604582
[TBL] [Abstract][Full Text] [Related]
3. UNC5293, a potent, orally available and highly MERTK-selective inhibitor.
Zheng H; Zhao J; Li B; Zhang W; Stashko MA; Minson KA; Huey MG; Zhou Y; Earp HS; Kireev D; Graham DK; DeRyckere D; Frye SV; Wang X
Eur J Med Chem; 2021 Aug; 220():113534. PubMed ID: 34038857
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
[TBL] [Abstract][Full Text] [Related]
5. Development and biological evaluation of[
Malik N; Kornelsen R; McCormick S; Colpo N; Merkens H; Bendre S; Benard F; Sossi V; Schirrmacher R; Schaffer P
Eur J Med Chem; 2021 Feb; 211():113005. PubMed ID: 33248850
[TBL] [Abstract][Full Text] [Related]
6. Automated synthesis of (R)-[
Rosenberg AJ; Cheung YY; Liu F; Peterson TE; Silverman J; Considine CM; Claassen DO
J Labelled Comp Radiopharm; 2022 Jun; 65(8):223-229. PubMed ID: 35491085
[TBL] [Abstract][Full Text] [Related]
7. Fluorine-18 radiolabeling and radiopharmacological characterization of a benzodioxolylpyrimidine-based radiotracer targeting the receptor tyrosine kinase EphB4.
Mamat C; Mosch B; Neuber C; Köckerling M; Bergmann R; Pietzsch J
ChemMedChem; 2012 Nov; 7(11):1991-2003. PubMed ID: 23042640
[TBL] [Abstract][Full Text] [Related]
8. Radiosynthesis and Biological Evaluation of [
Litchfield M; Wuest M; Glubrecht D; Wuest F
Mol Pharm; 2020 Jan; 17(1):251-261. PubMed ID: 31816246
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pre-clinical evaluation of a new class of high-affinity
Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991
[TBL] [Abstract][Full Text] [Related]
10. Molecular Imaging of Immune Cell Dynamics During De- and Remyelination in the Cuprizone Model of Multiple Sclerosis by [
Zinnhardt B; Belloy M; Fricke IB; Orije J; Guglielmetti C; Hermann S; Wagner S; Schäfers M; Van der Linden A; Jacobs AH
Theranostics; 2019; 9(6):1523-1537. PubMed ID: 31037121
[No Abstract] [Full Text] [Related]
11. The Synthesis and Initial Evaluation of MerTK Targeted PET Agents.
Wang L; Zhou Y; Wu X; Ma X; Li B; Ding R; Stashko MA; Wu Z; Wang X; Li Z
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268561
[TBL] [Abstract][Full Text] [Related]
12. Clinical Radiosynthesis and Translation of [
Jackson IM; Carlson ML; Beinat C; Malik N; Kalita M; Reyes S; Azevedo EC; Nagy SC; Alam IS; Sharma R; La Rosa SA; Moradi F; Cleland J; Shen B; James ML
ACS Chem Neurosci; 2023 Jul; 14(13):2416-2424. PubMed ID: 37310119
[TBL] [Abstract][Full Text] [Related]
13. Highly Selective MERTK Inhibitors Achieved by a Single Methyl Group.
Zhao J; Zhang D; Zhang W; Stashko MA; DeRyckere D; Vasileiadi E; Parker RE; Hunter D; Liu Q; Zhang Y; Norris-Drouin J; Li B; Drewry DH; Kireev D; Graham DK; Earp HS; Frye SV; Wang X
J Med Chem; 2018 Nov; 61(22):10242-10254. PubMed ID: 30347155
[TBL] [Abstract][Full Text] [Related]
14. Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors.
Haider A; Gobbi L; Kretz J; Ullmer C; Brink A; Honer M; Woltering TJ; Muri D; Iding H; Bürkler M; Binder M; Bartelmus C; Knuesel I; Pacher P; Herde AM; Spinelli F; Ahmed H; Atz K; Keller C; Weber M; Schibli R; Mu L; Grether U; Ametamey SM
J Med Chem; 2020 Sep; 63(18):10287-10306. PubMed ID: 32787079
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of a potent and selective (18)F-labeled delta-opioid receptor antagonist derived from the Dmt-Tic pharmacophore for positron emission tomography imaging.
Ryu EK; Wu Z; Chen K; Lazarus LH; Marczak ED; Sasaki Y; Ambo A; Salvadori S; Ren C; Zhao H; Balboni G; Chen X
J Med Chem; 2008 Mar; 51(6):1817-23. PubMed ID: 18311909
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and preliminary evaluation of
Lu X; Wang C; Li X; Gu P; Jia L; Zhang L
Bioorg Med Chem; 2019 Feb; 27(3):545-551. PubMed ID: 30611635
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Pharmacological Evaluation of [
Mu L; Müller Herde A; Rüefli PM; Sladojevich F; Milicevic Sephton S; Krämer SD; Thompson AJ; Schibli R; Ametamey SM; Lochner M
ACS Chem Neurosci; 2016 Nov; 7(11):1552-1564. PubMed ID: 27571447
[TBL] [Abstract][Full Text] [Related]
18. Facile fully automated radiosynthesis and quality control of O-(2-[
Wang M; Glick-Wilson BE; Zheng QH
Appl Radiat Isot; 2019 Dec; 154():108852. PubMed ID: 31442794
[TBL] [Abstract][Full Text] [Related]
19. Folate-PEG-NOTA-Al
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2017 Dec; 14(12):4353-4361. PubMed ID: 29028357
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
